Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa

Por Bergen, Phillip J., Li, Jian, Rayner, Craig R., Nation, Roger L.
Publicado em 2006

Pharmacokinetic/Pharmacodynamic Factors Influencing Emergence of Resistance to Linezolid in an In Vitro Model

Por Boak, Lauren M., Li, Jian, Rayner, Craig R., Nation, Roger L.
Publicado em 2007

Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients

Por Wallace, Stephanie J., Li, Jian, Rayner, Craig. R., Coulthard, Kingsley, Nation, Roger L.
Publicado em 2008

Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program

Por Meagher, Alison K., Forrest, Alan, Rayner, Craig R., Birmingham, Mary C., Schentag, Jerome J.
Publicado em 2003

Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response

Por Dobrovolny, Hana M., Reddy, Micaela B., Kamal, Mohamed A., Rayner, Craig R., Beauchemin, Catherine A. A.
Publicado em 2013

Initial Concentration-Time Profile of Gentamicin Determines Efficacy against Enterobacter cloacae ATCC 13047

Por Rayner, Craig R., Ioannides-Demos, Lisa L., Brien, Jo-Anne E., Liolios, Lisa L., Spicer, W. John
Publicado em 1998

Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma

Por Sudhakaran, Sreeja, Rayner, Craig R, Li, Jian, Kong, David C M, Gude, Neil M, Nation, Roger L
Publicado em 2007

Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus

Por Sudhakaran, Sreeja, Rayner, Craig R, Li, Jian, Kong, David C M, Gude, Neil M, Nation, Roger L
Publicado em 2008

Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii

Por Li, Jian, Rayner, Craig R., Nation, Roger L., Owen, Roxanne J., Spelman, Denis, Tan, Kar Eng, Liolios, Lisa
Publicado em 2006

Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis

Por Patel, Kashyap, Rayner, Craig R, Giraudon, Mylène, Kamal, Mohamed A, Morcos, Peter N, Robson, Richard, Kirkpatrick, Carl M
Publicado no Br J Clin Pharmacol (2015)

A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression

Por Kamal, Mohamed A., Gieschke, Ronald, Lemenuel-Diot, Annabelle, Beauchemin, Catherine A. A., Smith, Patrick F., Rayner, Craig R.
Publicado no Antimicrob Agents Chemother (2015)

Investigating Clinically Adequate Concentrations of Oseltamivir Carboxylate in End-Stage Renal Disease Patients Undergoing Hemodialysis Using a Population Pharmacokinetic Approach

Por Kamal, Mohamed A., Lien, Kayla Yi Ting, Robson, Richard, Subramoney, Vishak, Clinch, Barry, Rayner, Craig R., Gibiansky, Leonid
Publicado no Antimicrob Agents Chemother (2015)

Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression

Por Kamal, Mohamed A., Gieschke, Ronald, Lemenuel-Diot, Annabelle, Beauchemin, Catherine A. A., Smith, Patrick F., Rayner, Craig R.
Publicado no Antimicrob Agents Chemother (2016)

Nonclinical Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in the Central Nervous System

Por Hoffmann, Gerhard, Funk, Christoph, Fowler, Stephen, Otteneder, Michael B., Breidenbach, Alexander, Rayner, Craig R., Chu, Tom, Prinssen, Eric P.
Publicado em 2009

Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models

Por Dudhani, Rajesh V., Turnidge, John D., Coulthard, Kingsley, Milne, Robert W., Rayner, Craig R., Li, Jian, Nation, Roger L.
Publicado em 2010

Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa

Por Rees, Vanessa E., Bulitta, Jürgen B., Oliver, Antonio, Tsuji, Brian T., Rayner, Craig R., Nation, Roger L., Landersdorfer, Cornelia B.
Publicado no J Antimicrob Chemother (2016)

Differential Bidirectional Transfer of Indinavir in the Isolated Perfused Human Placenta

Por Sudhakaran, Sreeja, Ghabrial, Hany, Nation, Roger L., Kong, David C. M., Gude, Neil M., Angus, Peter W., Rayner, Craig R.
Publicado em 2005

Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens

Por Wallace, Stephanie J., Li, Jian, Nation, Roger L., Rayner, Craig R., Taylor, David, Middleton, Deborah, Milne, Robert W., Coulthard, Kingsley, Turnidge, John D.
Publicado em 2008

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design

Por Reddy, Micaela B., Yang, Kuo-Hsiung, Rao, Gauri, Rayner, Craig R., Nie, Jing, Pamulapati, Chandrasena, Marathe, Bindumadhav M., Forrest, Alan, Govorkova, Elena A.
Publicado no PLoS One (2015)

Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers

Por Brennan, Barbara J., Davies, Brian, Cirrincione-Dall, Georgina, Morcos, Peter N., Beryozkina, Anna, Chappey, Colombe, Aceves Baldó, Pau, Lennon-Chrimes, Sian, Rayner, Craig R.
Publicado em 2012